← All trials
NCT04552847
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 7, 2020
- Primary completion
- Jun 30, 2022
- Completion date
- Jun 30, 2023
- First posted
- Sep 17, 2020
- Last posted
- Oct 19, 2020
- Enrollment
- 95
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Katholieke Universiteit LeuvenLead sponsor
- Ghent UniversityCollaborator
- Katholieke Universiteit LeuvenOverall official - principal investigator
- University of AntwerpCollaborator
- Nederlands Neonataal Netwerk (N3), the NetherlandsCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.